2022 annual financial data
Denali Therapeutics 2022 Operating margin
Denali Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -314.16%.
Operating income was -340,744,000 USD and net income was -325,991,000 USD.
Operating cash flow was -244,716,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 108,463,000 USD
- Operating income
- -340,744,000 USD
- Net income
- -325,991,000 USD
- Operating cash flow
- -244,716,000 USD